STEMCELL Technologies Signs Exclusive License with IU Innovation and Commercialization Office for Inner Ear Organoid Technology
3/7/18: The company has signed an exclusive license with Indiana University Innovation and Commercialization Office for patented rights to groundbreaking inner ear organoid technologies.
STEMCELL Technologies to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent Stem Cells
STEMCELL Technologies announces the development of CloneR™, a novel medium formulation to aid researchers in their ability to successfully genome edit human pluripotent stem cells. This supplement represents a dramatic improvement over existing technologies. Editing the pluripotent stem...